General Hospital of Thessaloniki "G. Papanikolaou"
About General Hospital of Thessaloniki "G. Papanikolaou"
"ΓΕΝΙΚΟ ΝΟΣΟΚΟΜΕΙΟ ΘΕΣΣΑΛΟΝΙΚΗΣ"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at General Hospital of Thessaloniki "G. Papanikolaou"
During the past decade, General Hospital of Thessaloniki "G. Papanikolaou" conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 24 clinical trials were completed, i.e. on
average, 48% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 15 clinical trials were completed. i.e. 57.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
2006-07-28
2023-12-01
Active, not recruiting
790
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
2008-12-01
2016-12-01
Completed
59
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "General Hospital of Thessaloniki "G. Papanikolaou"" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Boehringer Ingelheim" with 9 trials
sponsored, "Celgene" with 8 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored and "George Papanicolaou Hospital"
with 7 trials sponsored. Other sponsors include 31 different institutions and
companies that sponsored additional 30 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital of Thessaloniki "G. Papanikolaou""
#1 collaborator was "George Papanicolaou Hospital" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "Pharmacyclics LLC." with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at General Hospital of Thessaloniki "G. Papanikolaou"
According to Clinical.Site data, the most researched conditions in "General Hospital of Thessaloniki "G. Papanikolaou"" are
"Multiple Myeloma" (8 trials), "Idiopathic Pulmonary Fibrosis" (6 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Relapsed or Refractory Multiple Myeloma" (4 trials) and "Beta-Thalassemia" (3 trials). Many other conditions were trialed in "General Hospital of Thessaloniki "G. Papanikolaou"" in a lesser frequency.
Clinical Trials Intervention Types at General Hospital of Thessaloniki "G. Papanikolaou"
Most popular intervention types in "General Hospital of Thessaloniki "G. Papanikolaou"" are "Drug" (68 trials), "Other" (5 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Dexamethasone" (9 trials), "Bortezomib" (6 trials), "Lenalidomide" (6 trials) and "Daratumumab" (5 trials). Other intervention names were less common.
Clinical Trials Genders at General Hospital of Thessaloniki "G. Papanikolaou"
The vast majority of trials in "General Hospital of Thessaloniki "G. Papanikolaou"" are
77 trials for "All" genders.
Clinical Trials Status at General Hospital of Thessaloniki "G. Papanikolaou"
Currently, there are 30 active trials in "General Hospital of Thessaloniki "G. Papanikolaou"".
1 are not yet recruiting,
14 are recruiting,
14 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 35 completed trials in General Hospital of Thessaloniki "G. Papanikolaou",
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in General Hospital of Thessaloniki "G. Papanikolaou", 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 54 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 7 trials that are defined as “Not Applicable".